F8-KO(2)

Nomenclature

C57BL/6Smoc-F8em3Smoc

Cat. NO.

NM-KO-200608

Strain State

Embryo cryopreservation

Export PDF

Gene Summary

Gene Symbol
F8

Synonyms

Cf8; Cf-8; FVIII

NCBI ID

14069

MGI ID

88383

Ensembl ID

ENSMUSG00000031196

Pubmed

F8

Human Ortholog

F8

Model Description

F8-KO(2) mice (Stock No.NM-KO-200608）carry a knockout allele derived from the targeted deletion of exon 1-26. While F8-KO mice (Stock No.NM-KO-00012) carrying the exon 16-19 deletion.
Research Application：Hemophilia A;HEMA

Disease Connection

factor VIII deficiency

Phenotype(s)

MGI:2449544

Reference(s)

Bi L, Lawler AM, Antonarakis SE, High KA, Gearhart JD, Kazazian HH Jr, Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A [letter]. Nat Genet. 1995 May;10(1):119-21

Validation Data

4.png

Fig1. Analysis of activated partial thromboplastin time (APTT) in the F8 knock-out mice. The coagulation time in F8-KO(2) (NM-KO-200608) was significantly longer than wild-type, and there was no obvious difference in coagulation time between F8-KO（NM-KO-00012）and F8-KO(2) (NM-KO-200608).


You may also like

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

Learn more
Customizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!

At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.

Learn more